Serum levels of follicle-stimulating hormone and luteinizing hormone after subcutaneous administration of human menopausal gonadotropin during pituitary suppression

Contains fulltext : 24875___.PDF (publisher's version ) (Open Access

Selective follicular reduction: what to do with the oocytes?

Contains fulltext : 25297___.PDF (publisher's version ) (Open Access

Geassisteerde voortplanting: medicijnen en technieken

Contains fulltext : 25894___.PDF (publisher's version ) (Open Access

In vitro fertilisatie: halen we de 65?

Item does not contain fulltex

Hormonal serum profiles and follicular development after intramuscular and pulsatile intravenous administration of human menopausal gonadotrophin

Contains fulltext : 22205___.PDF (publisher's version ) (Open Access

Follicular fluid hormone concentrations during controlled ovarian hyperstimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation

Contains fulltext : 25878___.PDF (publisher's version ) (Open Access

Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. 1. Comparison of an FSH-dominant and a purified FSH preparation

Contains fulltext : 25877___.PDF (publisher's version ) (Open Access

Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations

Contains fulltext : 24644___.PDF (publisher's version ) (Open Access

A comparison of recombinant human FSH (Puregon) and HMG in IVF cycles

Contains fulltext : 21562___.PDF (publisher's version ) (Open Access